Dr. Daniel Benasher, MD

Dr. Benasher practices at Port Jefferson Station Medical Oncology in Ridge, New York.

Dr. Benasher's NPI, 1780927558, was assigned on March 31, 2013. Dr. Benasher holds New York license 285149.

Dr. Benasher's primary practice is Port Jefferson Station Medical Oncology, at 1 Research Rd, Ridge, NY 11961. The practice phone is (631) 751-3000.

Dr. Benasher's primary practice is Port Jefferson Station Medical Oncology in Ridge, New York. Dr. Benasher is also affiliated with North Shore University Hospital. The medical group on file is New York Cancer & Blood Specialists. Dmand AI also links Dr. Benasher to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benasher practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Benasher's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Benasher is licensed in New York.

CMS data shows 7,055 Medicare services from Dr. Benasher across 41 procedure codes in 2024, for 685 Medicare patients. Medicare paid $221,490 for them.

CMS counts 685 Medicare patients who saw Dr. Benasher in 2024. The largest group is 65 to 74, with 257 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Benasher's median patient age at 58, with 61% women.

In 2024, Dr. Benasher wrote 599 Medicare Part D claims for 97 patients. 46% of them were for generic drugs. CMS names the drug for 351 of them, across 11 drugs with 11 or more claims each, at $951,760 in total drug cost. In 2023, CMS named 298 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Benasher for performance year 2024, reported as part of a group. Dr. Benasher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benasher as offering telehealth.

CMS Open Payments shows 60 general payments to Dr. Benasher from 29 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 83% of the total. Kite Pharma, Inc. paid the most, $213.